Related Experiment Videos

1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent

Life Sciences
|February 24, 1986
PubMed

Insights

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism. Its metabolite, 1-methyl-4-phenylpyridine (MPP+), shows potent systemic toxicity, primarily affecting the lungs and causing oxidative stress.

Area of Science:

  • Neuroscience
  • Toxicology

Background:

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to induce parkinsonism in primates.
  • Metabolism of MPTP to 1-methyl-4-phenylpyridine (MPP+) is considered crucial for its neurotoxic effects.
  • Directly assessing MPP+ effects in the brain is challenging, necessitating studies on peripheral toxicity.

Purpose of the Study:

  • To elucidate the mechanism of peripheral 1-methyl-4-phenylpyridine (MPP+) toxicity in rats and mice.
  • To understand the systemic pathological and chemical effects of MPP+.

Main Methods:

  • Systemic administration of 1-methyl-4-phenylpyridine (MPP+) to rats and mice.
  • Pathological examination of affected organs, focusing on lung tissue.
  • Measurement of plasma glutathione disulfide concentrations.
  • Assessment of MPP+ lethality in mice with dietary selenium deficiency.

Main Results:

  • Systemic MPP+ administration primarily caused lung pathology, characterized by perivascular edema.
  • Increased plasma glutathione disulfide concentrations indicated oxidative stress induced by MPP+.
  • Dietary selenium deficiency exacerbated the lethality of MPP+ in mice.

Conclusions:

  • 1-methyl-4-phenylpyridine (MPP+) exhibits potent systemic toxicity, with the lungs being a major target organ.
  • MPP+ induces oxidative stress, similar to paraquat.
  • The findings suggest MPP+ has the potential to significantly contribute to the central nervous system toxicity of MPTP, especially given its high concentration in primate brains.

Related Concept Videos